The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Journal for ImmunoTherapy of Cancer
(Nov 2020)
726 SRF114 is a fully human, CCR8 selective IgG1 antibody that induces destruction of tumor Tregs through ADCC
Christopher Wells,
Maria Scrivens,
Ernest Smith,
Michael Warren,
Pamela Holland,
Andrew Lake,
Sonia Das,
Vito Palombella,
Bijan Etemad-Gilbertson,
Austin Dulak
Affiliations
Christopher Wells
1Surface Oncology, Inc., Cambridge, MA, USA
Maria Scrivens
2Vaccinex, Inc., Rochester, NY, USA
Ernest Smith
2Vaccinex, Inc., Rochester, NY, USA
Michael Warren
1Surface Oncology, Inc., Cambridge, MA, USA
Pamela Holland
3Surface Oncology, Inc., Cambridge, MA, USA
Andrew Lake
1Surface Oncology, Inc., Cambridge, MA, USA
Sonia Das
1Surface Oncology, Inc., Cambridge, MA, USA
Vito Palombella
1Surface Oncology, Inc., Cambridge, MA, USA
Bijan Etemad-Gilbertson
1Surface Oncology, Inc., Cambridge, MA, USA
Austin Dulak
1Surface Oncology, Inc., Cambridge, MA, USA
DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0726
Journal volume & issue
Vol. 8, no. Suppl 3
Abstract
Read online
No abstracts available.
WeChat QR code
Close